study to see effect of the addition of yoga exercises in management of pelvic injury patients.

Not yet recruiting

• Conditions: Fracture of lumbar spine and pelvis,

• Registration Number: CTRI/2020/12/029994
• Lead Sponsor: Department of Science and Technology Government of India

Brief Summary

Pelvic trauma due to road traffic accidents leads to morbidity & poor quality of life. Pelvic ring constitutes a major part of pelvic and body stability and each additional bone fracture is associated with an increased likelihood of developing complications. Each additional bony element fracture increases the pain and developing infectious complications. Moreover, reduced mobility in pelvic trauma increases the likelihood of venous thrombosis. Benefits of yoga have been documented in many studies in patients of Asthma, Parkinsonism, multiple sclerosis, etc. but there is no literature available for the benefit of yoga in pelvic trauma patients. So, this study is intended to see the beneficial effects of Yoga in pelvic trauma patients in terms of immunity biomarkers, functional assessment, and quality of life.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-12-22
• Study Start: 2021-01-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Admitted patients Patients with pelvic injuries planned non-operative management.

Exclusion Criteria

• Neuro trauma patients with restricting mobility and/ or with decreased mental status.
• Patients undergoing any surgery for any other injury Patient with malignancies, coagulation and bleeding disorders Pre-existing disability/ comorbidity which may interfere with yoga therapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Functional assessment of pelvic injury patients.	up to 12 weeks
2.Quality of life of the pelvic injury patients	up to 12 weeks
3.Immune functional assessment by measuring immature cd35- to mature cd 35 + granulocytes ratio in peripheral blood.	up to 12 weeks

Secondary Outcome Measures

Name	Time	Method
na	na

Trial Locations

Locations (1)

AIIMS,New Delhi; 🇮🇳 South, DELHI, India

AIIMS,New Delhi

🇮🇳South, DELHI, India

Dr Dinesh Bagaria

Principal investigator

9914201918

dr_bagaria@yahoo.co.in